Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with <i>In vitro</i> and <i>In vivo</i> Antitumor Activity

Christine M. Chresta, Barry R. Davies, Ian Hickson et al. · Cancer Research · 2009 · 795 citations · Full text

Medicine, Oncology, Pharmacology +13

Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans

M. Susan DuPont, Andrea J. Day, Richard N. Bennett et al. · European Journal of Clinical Nutrition · 2004 · 197 citations

Pharmacy, Nutrition, Pharmacology +8

Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion.

Nancy H. Colburn, E. J. Wendel, George K. Abruzzo · Proceedings of the National Academy of Sciences · 1981 · 185 citations · Full text

Medicine, Cell Biology, Oncology +17

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

Qiang Wang, Yanlong Shi, Kai Zhou et al. · Cell Death and Disease · 2018 · 152 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell Transformation

Yong‐Yeon Cho, Ke Yao, Hong-Gyum Kim et al. · Cancer Research · 2007 · 122 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15